DESCRIPTIVE ANALYSIS OF THE CARFILZOMIB TOXICITY PROFILE IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE IN A THIRD LEVEL CENTER

被引：0
|
作者：
Gutierrez Lopez de Ocariz, X. [1 ]
Cuellar Perez-Avila, C. [1 ]
Zamanillo Herreros, I [1 ]
Iniguez Garcia, R. [1 ]
Poza Santaella, M. [1 ]
Alonso Fernandez, R. [1 ]
Sanchez Pina, J. M. [1 ]
Gonzalez Medina, J. [1 ]
Buenaventura Buendia, B. [1 ]
De Nicolas Sol, R. [1 ]
Vera Guerrero, E. [1 ]
Hidalgo Soto, M. [1 ]
Lopez Munoz, N. [1 ]
Lahuerta Palacios, J. J. [1 ]
Martinez Lopez, J. [1 ]
机构：
[1] Hosp Univ Octubre, Madrid, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-020
引用
收藏
页码：201 / 202
页数：2
相关论文
共 50 条
  • [21] HOME ADMINISTRATION OF CARFILZOMIB IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA DURING THE COVID-19 PANDEMIC. EXPERIENCE OF A CENTER
    Luis Miguel, Juarez-Salcedo
    Rodriguez Cristina, Encinas
    Centurion Ignacio, Gomez
    Pena Eva, Gonzalez-Haba
    Maria Norberta, Sanchez Fresneda
    Jose Luis, Revuelta Herrero
    Menendez Carmen, Garcia
    Maria Jose, Garcia Sanguino
    Maria Jose, Martinez Carreno
    Mi, Kwon
    HAEMATOLOGICA, 2021, 106 (10) : 137 - 138
  • [22] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MIXED MODALITY AT HOME IN PATIENTS WITH MULTIPLE MYELOMA. EXPERIENCE OF A SINGLE CENTER
    Ignacio, Gomez-Centurion
    Cristina, Encinas
    Luis Mi-Guel, Juarez Salcedo
    Gillen, Oarbeascoa
    Carmen, Garcia
    Fresnena Carmen, Lopez
    Maria Josefa, Martinez Carreno
    Vilaplana Vicente, Escudero
    Haba Eva, Gonzalez
    Rebeca, Bailen
    Javier, Anguita
    Jose Luis, Diez-Martin
    Mi, Kwon
    HAEMATOLOGICA, 2021, 106 (10) : 268 - 269
  • [23] EFFICACY AND SAFETY OF THE CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE AND CARFILZOMIB-DEXAMETHASONE SCHEME IN PATIENTS WITH MULTIPLE MYELOMA IN RELAPSE OR REFRACTORY. EXPERIENCE IN OUR CENTER
    Gimeno Brosel, M. T.
    Lancharro Anchel, A.
    Garcia Navarro, I
    Gascon Buj, A.
    Garcia Boyero, R.
    Linares Latorre, D.
    Clavel, P. J.
    Serrano Picazo, L.
    Fernandez Delgado, M. M.
    Carrascosa Mastell, P.
    Contreras Tornero, M. B.
    Canigral Ferrando, G.
    HAEMATOLOGICA, 2017, 102 : 93 - 94
  • [24] Mobilization of peripheral blood progenitors in multiple myeloma. How to deal with hard to mobilize myeloma patients-six years center experience
    Pivkova, A.
    Stavrik, S. Genadieva
    Cevreska, L.
    Stojanoski, Z.
    Krstevska, S. Balkanova
    Karanfilski, O.
    Georgievski, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 494 - 494
  • [25] Argentine Multicentric Experience of Carfilzomib Use in Relapsed / Refractory Multiple Myeloma. Report from the GAMM (Grupo Argentino de Mieloma Multiple)
    Schutz, Natalia Paola
    Duarte, Patricio
    Shanley, Claudia
    Cia, Agustina
    Ochoa, Paola
    Corzo, Ariel
    Quiroga, Luis Dario
    Orlando, Sergio Mario
    Mariano, Romina
    Enrico, Alicia
    Riveros, Dardo
    Remaggi, Guillermina
    Fantl, Dorotea Beatriz
    BLOOD, 2017, 130
  • [26] Molecular analysis in the clinical follow up of patients with multiple myeloma.
    Marinelli, G
    Terragna, C
    Cavo, K
    Lemoli, RM
    Bandini, G
    Zamagni, E
    Ronconi, S
    Tosi, P
    Mangianti, S
    Motta, MR
    Zagarella, MS
    Testoni, N
    Amabile, M
    Ottaviani, E
    Tura, S
    BLOOD, 1999, 94 (10) : 384B - 384B
  • [27] Mutation and expression analysis of PTEN gene in patients with multiple myeloma.
    Li, J
    Xiong, WJ
    Luo, SK
    Hong, WD
    BLOOD, 2003, 102 (11) : 362B - 362B
  • [28] An Observational, Retrospective Analysis of Retreatment with Carfilzomib in the Management of Patients with Multiple Myeloma
    Peterson, Tim J.
    Korde, Neha
    Hassoun, Hani
    Mailankody, Sham
    Lesokhin, Alexander M.
    Hultcrantz, Malin
    Shah, Urvi A.
    Smith, Eric L.
    Lu, Sydney X.
    Landau, Heather J.
    Shah, Gunjan L.
    Scordo, Michael
    Lahoud, Oscar B.
    Giralt, Sergio A.
    Landgren, Ola
    BLOOD, 2019, 134
  • [29] Clinical & Haematological Profile of Multiple Myeloma Patients: A Single Center Experience from Sindh, Pakistan
    Hafeez, Nazia
    Ujjan, Ikram
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S15 - S15
  • [30] Circulating proteasome level is an independent prognostic factor for survival in patients with multiple myeloma.
    Jakob, C
    Egerer, K
    Feist, E
    Zavrski, I
    Eucker, J
    Heider, U
    Burmester, G
    Possinger, K
    Kloetzel, PM
    Sezer, O
    BLOOD, 2004, 104 (11) : 415A - 415A
12345